181 related articles for article (PubMed ID: 12558131)
1. Effects of the angiotensin-converting enzyme inhibitor enalapril on sympathetic neuronal function and beta-adrenergic desensitization in heart failure after myocardial infarction in rats.
Igawa A; Nozawa T; Yoshida N; Fujii N; Kato B; Inoue M; Tazawa S; Yamada Y; Asanoi H; Inoue H
Jpn Heart J; 2002 Nov; 43(6):675-88. PubMed ID: 12558131
[TBL] [Abstract][Full Text] [Related]
2. Long-term treatment with angiotensin I-converting enzyme inhibitors attenuates the loss of cardiac beta-adrenoceptor responses in rats with chronic heart failure.
Sanbe A; Takeo S
Circulation; 1995 Nov; 92(9):2666-75. PubMed ID: 7586371
[TBL] [Abstract][Full Text] [Related]
3. ACE inhibition improves cardiac NE uptake and attenuates sympathetic nerve terminal abnormalities in heart failure.
Kawai H; Fan TH; Dong E; Siddiqui RA; Yatani A; Stevens SY; Liang CS
Am J Physiol; 1999 Oct; 277(4):H1609-17. PubMed ID: 10516201
[TBL] [Abstract][Full Text] [Related]
4. Both enalapril and losartan attenuate sarcolemmal Na+-K+-ATPase remodeling in failing rat heart due to myocardial infarction.
Guo X; Wang J; Elimban V; Dhalla NS
Can J Physiol Pharmacol; 2008 Apr; 86(4):139-47. PubMed ID: 18418421
[TBL] [Abstract][Full Text] [Related]
5. Changes in beta-adrenoceptors in heart failure due to myocardial infarction are attenuated by blockade of renin-angiotensin system.
Sethi R; Shao Q; Ren B; Saini HK; Takeda N; Dhalla NS
Mol Cell Biochem; 2004 Aug; 263(1-2):11-20. PubMed ID: 15524163
[TBL] [Abstract][Full Text] [Related]
6. Effects of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on beta-adrenoceptor signaling in heart failure produced by myocardial Infarction in rabbits: reversal of altered expression of beta-adrenoceptor kinase and G i alpha.
Makino T; Hattori Y; Matsuda N; Onozuka H; Sakuma I; Kitabatake A
J Pharmacol Exp Ther; 2003 Jan; 304(1):370-9. PubMed ID: 12490614
[TBL] [Abstract][Full Text] [Related]
7. Additional effects of endothelin receptor blockade and angiotensin converting enzyme inhibition in rats with chronic heart failure.
Qiu CB; Qiu CS; Hess P; Clozel JP; Clozel M
Acta Pharmacol Sin; 2001 Jun; 22(6):541-8. PubMed ID: 11747762
[TBL] [Abstract][Full Text] [Related]
8. Effects of a DA2/alpha2 agonist and a beta1-blocker in combination with an ACE inhibitor on adrenergic activity and left ventricular remodeling in an experimental model of left ventricular dysfunction after coronary artery occlusion.
Masson S; Masseroli M; Fiordaliso F; Calvillo L; D'Aquila S; Bernasconi R; Garrido G; Torri M; Razzetti R; Bongrani S; Latini R
J Cardiovasc Pharmacol; 1999 Sep; 34(3):321-6. PubMed ID: 10470987
[TBL] [Abstract][Full Text] [Related]
9. Captopril enhances intracellular calcium handling and beta-adrenergic responsiveness of myocardium from rats with postinfarction failure.
Litwin SE; Morgan JP
Circ Res; 1992 Oct; 71(4):797-807. PubMed ID: 1325296
[TBL] [Abstract][Full Text] [Related]
10. Converting enzyme inhibition after experimental myocardial infarction in rats: comparative study between spirapril and zofenopril.
van Wijngaarden J; Pinto YM; van Gilst WH; de Graeff PA; de Langen CD; Wesseling H
Cardiovasc Res; 1991 Nov; 25(11):936-42. PubMed ID: 1813122
[TBL] [Abstract][Full Text] [Related]
11. Dipeptidyl peptidase-4 inhibitor improves cardiac function by attenuating adverse cardiac remodelling in rats with chronic myocardial infarction.
Inthachai T; Lekawanvijit S; Kumfu S; Apaijai N; Pongkan W; Chattipakorn SC; Chattipakorn N
Exp Physiol; 2015 Jun; 100(6):667-79. PubMed ID: 25823534
[TBL] [Abstract][Full Text] [Related]
12. Physical training promotes similar effects to the blockade of angiotensin-converting enzyme on the cardiac morphology and function in old female rats subjected to premature ovarian failure.
Felix ACS; Dutra SGV; Gastaldi AC; Bonfim PC; Vieira S; de Souza HCD
Exp Gerontol; 2018 Aug; 109():90-98. PubMed ID: 28408160
[TBL] [Abstract][Full Text] [Related]
13. Effects of beta-adrenergic blockade on papillary muscle function and the beta-adrenergic receptor system in noninfarcted myocardium in compensated ischemic left ventricular dysfunction.
Warner AL; Bellah KL; Raya TE; Roeske WR; Goldman S
Circulation; 1992 Nov; 86(5):1584-95. PubMed ID: 1330362
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.
Schieffer B; Wirger A; Meybrunn M; Seitz S; Holtz J; Riede UN; Drexler H
Circulation; 1994 May; 89(5):2273-82. PubMed ID: 8181153
[TBL] [Abstract][Full Text] [Related]
15. Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat.
Ocaranza MP; Godoy I; Jalil JE; Varas M; Collantes P; Pinto M; Roman M; Ramirez C; Copaja M; Diaz-Araya G; Castro P; Lavandero S
Hypertension; 2006 Oct; 48(4):572-8. PubMed ID: 16908757
[TBL] [Abstract][Full Text] [Related]
16. A natural p300-specific histone acetyltransferase inhibitor, curcumin, in addition to angiotensin-converting enzyme inhibitor, exerts beneficial effects on left ventricular systolic function after myocardial infarction in rats.
Sunagawa Y; Morimoto T; Wada H; Takaya T; Katanasaka Y; Kawamura T; Yanagi S; Marui A; Sakata R; Shimatsu A; Kimura T; Kakeya H; Fujita M; Hasegawa K
Circ J; 2011; 75(9):2151-9. PubMed ID: 21737953
[TBL] [Abstract][Full Text] [Related]
17. Modification of myosin protein and gene expression in failing hearts due to myocardial infarction by enalapril or losartan.
Wang J; Guo X; Dhalla NS
Biochim Biophys Acta; 2004 Oct; 1690(2):177-84. PubMed ID: 15469907
[TBL] [Abstract][Full Text] [Related]
18. Divergent effects of angiotensin-converting enzyme inhibition and angiotensin II-receptor antagonism on myocardial cellular proliferation and collagen deposition after myocardial infarction in rats.
Taylor K; Patten RD; Smith JJ; Aronovitz MJ; Wight J; Salomon RN; Konstam MA
J Cardiovasc Pharmacol; 1998 May; 31(5):654-60. PubMed ID: 9593063
[TBL] [Abstract][Full Text] [Related]
19. Effect of L-2286, a poly(ADP-ribose)polymerase inhibitor and enalapril on myocardial remodeling and heart failure.
Bartha E; Kiss GN; Kalman E; Kulcsár G; Kálai T; Hideg K; Habon T; Sumegi B; Toth K; Halmosi R
J Cardiovasc Pharmacol; 2008 Sep; 52(3):253-61. PubMed ID: 18806606
[TBL] [Abstract][Full Text] [Related]
20. Effects of the calcium channel antagonist mibefradil on haemodynamic parameters and myocardial Ca(2+)-handling in infarct-induced heart failure in rats.
Sandmann S; Min JY; Meissner A; Unger T
Cardiovasc Res; 1999 Oct; 44(1):67-80. PubMed ID: 10615391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
